The Claim
Twelve months of daily supplementation with lutein, zeaxanthin, omega-3-LCPUFAs, and antioxidants improves best-corrected visual acuity in patients with non-exudative age-related macular degeneration compared to placebo.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking a daily supplement containing lutein, zeaxanthin, omega-3-LCPUFAs, and antioxidants for one year leads to measurable improvement in sharpness of vision in people with non-exudative age-related macular degeneration compared to taking a placebo.
See the scientific wording
Twelve months of daily supplementation with lutein, zeaxanthin, omega-3-LCPUFAs, and antioxidants improves best-corrected visual acuity in patients with non-exudative age-related macular degeneration, with statistically significant gains observed compared to placebo.
Lutein and zeaxanthin from supplements build up in the central part of the eye, where they block harmful blue light and neutralize damaging molecules. Omega-3 fats become part of the light-sensing cells, making their membranes more flexible and reducing inflammation. Together, these changes protect the cells that detect light, allowing them to send clearer signals to the brain, which improves the ability to see fine details.
What the research says
1 studyPeople with early macular degeneration who took a daily vitamin pill containing lutein, zeaxanthin, omega-3s, and antioxidants for a year could read eye charts slightly better than those who took a sugar pill — the study proved it.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.